Person · CIK 1157983

R. Martin Chavez

Director at Alphabet

Earlier: Recursion Pharmaceuticals, Goldman Sachs Group and PNM Resources

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$6.2M

Noticed on Form 144$0

Bought on Form 4$0

Companies4

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

Company	Security	Held	Shares or units	As of
Alphabet GOOG	Class C Capital Stock	Directly	9,989	Sep 14, 2026 · Filing · EDGAR
Alphabet GOOG	Class C Google Stock Units	Directly	941	Sep 14, 2026 · Filing · EDGAR
Recursion Pharmaceuticals	Class A Common Stock	Directly	60,078	Apr 1, 2024 · Filing · EDGAR
Recursion Pharmaceuticals	Stock Option (Right to Buy) exercise $2.22, expires Apr 22, 2030, into Class A Common Stock	Directly	525,000	Jun 16, 2023 · Filing · EDGAR
Recursion Pharmaceuticals	Stock Option (Right to Buy) exercise $6.20, expires Jun 14, 2032, into Class A Common Stock	Directly	36,290	Jun 16, 2023 · Filing · EDGAR
Recursion Pharmaceuticals	Stock Option (Right to Buy) exercise $8.92, expires Jun 16, 2033, into Class A Common Stock	Directly	25,224	Jun 16, 2023 · Filing · EDGAR
Recursion Pharmaceuticals	Stock Option (Right to Buy) exercise $18.00, expires Apr 15, 2031, into Class A Common Stock	Directly	12,500	Jun 16, 2023 · Filing · EDGAR
Goldman Sachs Group	Common Stock, par value $0.01 per share	Directly	76,829	Feb 7, 2018 · Filing · EDGAR
PNM Resources	COMMON STOCK	Directly	1,427	Mar 10, 2004 · Filing · EDGAR

Sold and noticed by quarter

No sales or Form 144 notices with a stated value.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

No Form 144 notices with structured data (filed on EDGAR since April 2023).

Notice date	Noticed	Planned sale	Outcome	Links
Sales without a matching Form 144 · 15 sales No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
—	—	—	Notice not machine-readable Goldman Sachs Group: Sold 500 at $260.43 on Feb 7, 2018 · $130K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Goldman Sachs Group: Sold 500 at $259.26 on Feb 7, 2018 · $130K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Goldman Sachs Group: Sold 540 at $257.39 on Feb 7, 2018 · $139K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Goldman Sachs Group: Sold 300 at $261.27 on Feb 7, 2018 · $78K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Goldman Sachs Group: Sold 2,656 at $260.44 on Feb 7, 2018 · $692K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Goldman Sachs Group: Sold 3,958 at $259.44 on Feb 7, 2018 · $1M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Goldman Sachs Group: Sold 1,800 at $258.38 on Feb 7, 2018 · $465K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Goldman Sachs Group: Sold 1,575 at $257.46 on Feb 7, 2018 · $405K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Goldman Sachs Group: Sold 800 at $269.53 on Jan 31, 2018 · $216K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Goldman Sachs Group: Sold 540 at $268.45 on Jan 31, 2018 · $145K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Goldman Sachs Group: Sold 200 at $266.96 on Jan 31, 2018 · $53K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Goldman Sachs Group: Sold 3,164 at $269.72 on Jan 31, 2018 · $853K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Goldman Sachs Group: Sold 3,474 at $268.92 on Jan 31, 2018 · $934K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Goldman Sachs Group: Sold 2,108 at $268.14 on Jan 31, 2018 · $565K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Goldman Sachs Group: Sold 1,543 at $267.01 on Jan 31, 2018 · $412K (10b5-1 plan)	Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Alphabet GOOG Director · filings 2022 to 2026

Date	Transaction	Shares	Held after	Source
Sep 14, 2026	Grant or award from the company	+0.4	597 direct	Filing · EDGAR
Sep 14, 2026	Grant or award from the company	+1	903 direct	Filing · EDGAR
Sep 14, 2026	Grant or award from the company	+1	1,433 direct	Filing · EDGAR
Sep 14, 2026	Grant or award from the company	+1	941 direct	Filing · EDGAR
Sep 1, 2026	Gift	−1,181	9,989 direct	Filing · EDGAR
Jul 1, 2026	Grant or award from the company	+980	980 direct	Filing · EDGAR
Jun 15, 2026	Grant or award from the company	+0.2	371 direct	Filing · EDGAR
Jun 15, 2026	Grant or award from the company	+0.5	777 direct	Filing · EDGAR
Jun 15, 2026	Grant or award from the company	+1	1,026 direct	Filing · EDGAR
Jun 15, 2026	Grant or award from the company	+1	1,558 direct	Filing · EDGAR
Mar 16, 2026	Grant or award from the company	+1	927 direct	Filing · EDGAR
Mar 16, 2026	Grant or award from the company	+1	955 direct	Filing · EDGAR
Mar 16, 2026	Grant or award from the company	+1	1,148 direct	Filing · EDGAR
Mar 16, 2026	Grant or award from the company	+1	1,684 direct	Filing · EDGAR
Dec 15, 2025	Grant or award from the company	+1	1,482 direct	Filing · EDGAR
Dec 15, 2025	Grant or award from the company	+0.8	1,133 direct	Filing · EDGAR
Dec 15, 2025	Grant or award from the company	+0.9	1,270 direct	Filing · EDGAR
Dec 15, 2025	Grant or award from the company	+1	1,809 direct	Filing · EDGAR
Nov 19, 2025	Gift	−1,727	8,036 direct	Filing · EDGAR
Sep 15, 2025	Grant or award from the company	+2	2,036 direct	Filing · EDGAR
Sep 15, 2025	Grant or award from the company	+1	1,312 direct	Filing · EDGAR
Sep 15, 2025	Grant or award from the company	+1	1,392 direct	Filing · EDGAR
Sep 15, 2025	Grant or award from the company	+2	1,934 direct	Filing · EDGAR
Jul 2, 2025	Grant or award from the company	+2,016	2,016 direct	Filing · EDGAR
Jun 16, 2025	Grant or award from the company	+3	2,589 direct	Filing · EDGAR
Jun 16, 2025	Grant or award from the company	+2	1,489 direct	Filing · EDGAR
Jun 16, 2025	Grant or award from the company	+2	1,513 direct	Filing · EDGAR
Mar 17, 2025	Grant or award from the company	+4	3,140 direct	Filing · EDGAR
Mar 17, 2025	Grant or award from the company	+2	1,666 direct	Filing · EDGAR
Mar 17, 2025	Grant or award from the company	+2	1,634 direct	Filing · EDGAR
Dec 16, 2024	Grant or award from the company	+4	3,689 direct	Filing · EDGAR
Dec 16, 2024	Grant or award from the company	+2	1,841 direct	Filing · EDGAR
Dec 16, 2024	Grant or award from the company	+2	1,754 direct	Filing · EDGAR
Sep 16, 2024	Grant or award from the company	+5	4,239 direct	Filing · EDGAR
Sep 16, 2024	Grant or award from the company	+3	2,018 direct	Filing · EDGAR
Sep 16, 2024	Grant or award from the company	+2	1,874 direct	Filing · EDGAR
Jul 3, 2024	Grant or award from the company	+1,953	1,953 direct	Filing · EDGAR
Jun 17, 2024	Grant or award from the company	+2	2,192 direct	Filing · EDGAR
Jun 17, 2024	Grant or award from the company	+5	4,785 direct	Filing · EDGAR
Jul 5, 2023	Grant or award from the company	+2,841	2,841 direct	Filing · EDGAR
Aug 3, 2022	Grant or award from the company	+8,824	8,824 direct	Filing · EDGAR

Recursion Pharmaceuticals Director · filings 2021 to 2024

Date	Transaction	Shares	Held after	Source
Apr 1, 2024	Grant or award from the company	+2,001	60,078 direct	Filing · EDGAR
Jan 2, 2024	Grant or award from the company	+1,900	58,077 direct	Filing · EDGAR
Oct 2, 2023	Grant or award from the company	+2,619	56,177 direct	Filing · EDGAR
Jul 3, 2023	Grant or award from the company	+2,541	53,558 direct	Filing · EDGAR
Jun 16, 2023	Grant or award from the company	+12,612	51,017 direct	Filing · EDGAR
Jun 16, 2023	Grant or award from the company Stock Option (Right to Buy)	+25,224	25,224 direct	Filing · EDGAR
Apr 3, 2023	Grant or award from the company	+2,721	38,405 direct	Filing · EDGAR
Jan 3, 2023	Grant or award from the company	+2,483	35,684 direct	Filing · EDGAR
Oct 3, 2022	Grant or award from the company	+1,725	33,201 direct	Filing · EDGAR
Jul 1, 2022	Grant or award from the company	+2,224	31,476 direct	Filing · EDGAR
Jun 14, 2022	Grant or award from the company	+18,145	29,252 direct	Filing · EDGAR
Jun 14, 2022	Grant or award from the company Stock Option (right to buy)	+36,290	36,290 direct	Filing · EDGAR
Apr 1, 2022	Grant or award from the company	+2,438	11,107 direct	Filing · EDGAR
Jan 3, 2022	Grant or award from the company	+1,040	8,669 direct	Filing · EDGAR
Oct 1, 2021	Grant or award from the company	+858	7,629 direct	Filing · EDGAR
Jul 1, 2021	Grant or award from the company	+521	6,771 direct	Filing · EDGAR
Apr 20, 2021	Derivative converted	−6,250	0 direct	Filing · EDGAR
Apr 20, 2021	Derivative converted	+6,250	6,250 direct	Filing · EDGAR
Apr 20, 2021	Derivative converted Stock Option (Right to Buy)	−12,500	0 direct	Filing · EDGAR
Apr 20, 2021	Derivative converted Stock Option (Right to Buy)	+12,500	12,500 direct	Filing · EDGAR
Apr 20, 2021	Derivative converted Stock Option (Right to Buy)	−525,000	0 direct	Filing · EDGAR
Apr 20, 2021	Derivative converted Stock Option (Right to Buy)	+525,000	525,000 direct	Filing · EDGAR
Apr 16, 2021	Grant or award from the company	+6,250	6,250 direct	Filing · EDGAR
Apr 15, 2021	Grant or award from the company Stock Option (Right to Buy)	+12,500	12,500 direct	Filing · EDGAR

Goldman Sachs Group Executive Vice President - CFO · filings 2017 to 2018 · sold $6.2M

Date	Transaction	Shares	Price	Value	Held after	Source
Feb 7, 2018	Sale under a 10b5-1 plan	−1,575	$257.46	$405K	85,543 direct	Filing · EDGAR
Feb 7, 2018	Sale under a 10b5-1 plan	−1,800	$258.38	$465K	83,743 direct	Filing · EDGAR
Feb 7, 2018	Sale under a 10b5-1 plan	−3,958	$259.44	$1M	79,785 direct	Filing · EDGAR
Feb 7, 2018	Sale under a 10b5-1 plan	−2,656	$260.44	$692K	77,129 direct	Filing · EDGAR
Feb 7, 2018	Sale under a 10b5-1 plan	−300	$261.27	$78K	76,829 direct	Filing · EDGAR
Feb 7, 2018	Sale under a 10b5-1 plan	−540	$257.39	$139K	1,000 See footnote	Filing · EDGAR
Feb 7, 2018	Sale under a 10b5-1 plan	−500	$259.26	$130K	500 See footnote	Filing · EDGAR
Feb 7, 2018	Sale under a 10b5-1 plan	−500	$260.43	$130K	0 See footnote	Filing · EDGAR
Jan 31, 2018	Sale under a 10b5-1 plan	−1,543	$267.01	$412K	95,864 direct	Filing · EDGAR
Jan 31, 2018	Sale under a 10b5-1 plan	−2,108	$268.14	$565K	93,756 direct	Filing · EDGAR
Jan 31, 2018	Sale under a 10b5-1 plan	−3,474	$268.92	$934K	90,282 direct	Filing · EDGAR
Jan 31, 2018	Sale under a 10b5-1 plan	−3,164	$269.72	$853K	87,118 direct	Filing · EDGAR
Jan 31, 2018	Sale under a 10b5-1 plan	−200	$266.96	$53K	2,880 See footnote	Filing · EDGAR
Jan 31, 2018	Sale under a 10b5-1 plan	−540	$268.45	$145K	2,340 See footnote	Filing · EDGAR
Jan 31, 2018	Sale under a 10b5-1 plan	−800	$269.53	$216K	1,540 See footnote	Filing · EDGAR
Dec 28, 2017	Option or RSU exercised or converted	+58,108			129,842 direct	Filing · EDGAR
Dec 28, 2017	Shares withheld for tax or exercise price	−32,435	$255.95	$8.3M	97,407 direct	Filing · EDGAR
Dec 28, 2017	Option or RSU exercised or converted Restricted Stock Units	−58,108			0 direct	Filing · EDGAR

PNM Resources Director · filings 2003 to 2004

Date	Transaction	Shares	Price	Value	Held after	Source
May 18, 2004	Grant or award from the company STOCK OPTIONS	+5,000	$28.70	$144K	15,000 direct	Filing · EDGAR
Mar 10, 2004	Grant or award from the company	+1,000	$30.57	$31K	1,427 direct	Filing · EDGAR

All 51 Forms 3, 4, 5 and 144

Filed	Form	Company	Links
Sep 16, 2026	Form 4	Alphabet GOOG	Filing · EDGAR
Sep 3, 2026	Form 4	Alphabet GOOG	Filing · EDGAR
Jul 6, 2026	Form 4	Alphabet GOOG	Filing · EDGAR
Jun 17, 2026	Form 4	Alphabet GOOG	Filing · EDGAR
Mar 18, 2026	Form 4	Alphabet GOOG	Filing · EDGAR
Feb 17, 2026	Form 5	Alphabet GOOG	Filing · EDGAR
Dec 17, 2025	Form 4	Alphabet GOOG	Filing · EDGAR
Sep 17, 2025	Form 4	Alphabet GOOG	Filing · EDGAR
Jul 11, 2025	Form 4	Alphabet GOOG	Filing · EDGAR
Jun 18, 2025	Form 4	Alphabet GOOG	Filing · EDGAR
Mar 18, 2025	Form 4	Alphabet GOOG	Filing · EDGAR
Feb 14, 2025	Form 5	Alphabet GOOG	Filing · EDGAR
Dec 17, 2024	Form 4	Alphabet GOOG	Filing · EDGAR
Sep 18, 2024	Form 4	Alphabet GOOG	Filing · EDGAR
Jul 5, 2024	Form 4	Alphabet GOOG	Filing · EDGAR
Jun 18, 2024	Form 4	Alphabet GOOG	Filing · EDGAR
Apr 3, 2024	Form 4	Recursion Pharmaceuticals	Filing · EDGAR
Feb 13, 2024	Form 5	Alphabet GOOG	Filing · EDGAR
Jan 4, 2024	Form 4	Recursion Pharmaceuticals	Filing · EDGAR
Oct 4, 2023	Form 4	Recursion Pharmaceuticals	Filing · EDGAR
Jul 6, 2023	Form 4	Alphabet GOOG	Filing · EDGAR
Jul 6, 2023	Form 4	Recursion Pharmaceuticals	Filing · EDGAR
Jun 21, 2023	Form 4	Recursion Pharmaceuticals	Filing · EDGAR
Apr 5, 2023	Form 4	Recursion Pharmaceuticals	Filing · EDGAR
Jan 5, 2023	Form 4	Recursion Pharmaceuticals	Filing · EDGAR
Oct 5, 2022	Form 4	Recursion Pharmaceuticals	Filing · EDGAR
Aug 9, 2022	Form 4	Alphabet GOOG	Filing · EDGAR
Jul 19, 2022	Form 3	Alphabet GOOG	Filing · EDGAR
Jul 6, 2022	Form 4	Recursion Pharmaceuticals	Filing · EDGAR
Jun 16, 2022	Form 4	Recursion Pharmaceuticals	Filing · EDGAR
Apr 5, 2022	Form 4	Recursion Pharmaceuticals	Filing · EDGAR
Jan 5, 2022	Form 4	Recursion Pharmaceuticals	Filing · EDGAR
Oct 5, 2021	Form 4	Recursion Pharmaceuticals	Filing · EDGAR
Jul 6, 2021	Form 4	Recursion Pharmaceuticals	Filing · EDGAR
Apr 22, 2021	Form 4	Recursion Pharmaceuticals	Filing · EDGAR
Apr 19, 2021	Form 4	Recursion Pharmaceuticals	Filing · EDGAR
Apr 15, 2021	Form 3	Recursion Pharmaceuticals	Filing · EDGAR
Feb 9, 2018	Form 4	Goldman Sachs Group	Filing · EDGAR
Feb 2, 2018	Form 4	Goldman Sachs Group	Filing · EDGAR
Dec 29, 2017	Form 4	Goldman Sachs Group	Filing · EDGAR
May 1, 2017	Form 3	Goldman Sachs Group	Filing · EDGAR
May 19, 2004	Form 4	PNM Resources	Filing · EDGAR
Mar 10, 2004	Form 4	PNM Resources	Filing · EDGAR
May 14, 2003	Form 4	PNM Resources	Filing · EDGAR
Sep 3, 2002	Form 4	Paper or text filing, not machine-readable	EDGAR
Aug 22, 2002	Form 4	Paper or text filing, not machine-readable	EDGAR
Aug 22, 2002	Form 4	Paper or text filing, not machine-readable	EDGAR
May 30, 2002	Form 4	Paper or text filing, not machine-readable	EDGAR
May 30, 2002	Form 4	Paper or text filing, not machine-readable	EDGAR
Mar 7, 2002	Form 4	Paper or text filing, not machine-readable	EDGAR
Aug 22, 2001	Form 3	Paper or text filing, not machine-readable	EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.